文献速递乳腺癌放疗胸部肿瘤放疗放疗物理与技术

年轻非裔美国女性I-IIIA期乳腺癌幸存者放疗相关第二原发恶性肿瘤风险升高

Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-06-12

该研究基于SEER 9登记处1988-2008年诊断为I-IIIA期乳腺癌的20-44岁女性,分析放疗与非乳腺第二原发恶性肿瘤(SMN)风险的关系。结果显示,非裔美国女性放疗后25年SMN累积发生率为5.2% vs 3.6%(HR=1.81,95% BCI 1.02-2.50,P<.05),白人女性为6.4% vs 5.9%(HR=1.10,95% BCI 0.61-1.40,P>.05)。非裔美国女性放疗相关SMN风险更高,尤其是肺癌。

要点

  • 年轻非裔美国女性乳腺癌幸存者放疗后非乳腺SMN风险显著升高(HR=1.81)。
  • 白人女性放疗相关SMN风险未达统计学显著(HR=1.10)。
  • 非裔美国女性正常气道上皮放射耐受性评分显著低于白人女性(P=.038)。

核心结论

  • 在预计25年随访下,放疗与年轻I-IIIA期乳腺癌幸存者非乳腺SMN风险升高相关,尤其是第二肺癌。
  • 放疗相关非乳腺SMN在非裔美国女性中高于白人女性。

研究设计与样本

  • 基于SEER 9登记处1988-2008年诊断为I-IIIA期乳腺癌的20-44岁女性,共识别20,516例 eligible 患者,包括2,183例非裔美国人和16,009例白人。
  • 采用Bootstrapping方法和竞争风险比例风险模型评估放疗对非乳腺SMN风险的影响,并在种族亚组中重复分析。
  • 利用Gene Expression Omnibus(GEO)数据集对正常气道上皮进行放射耐受性评分分析。

主要发现

  • 非裔美国女性放疗组与未放疗组25年SMN累积发生率分别为5.2%和3.6%,中位随访分别为12.8年和17.4年(HR=1.81;95% BCI 1.02-2.50;P<.05)。
  • 白人女性放疗组与未放疗组25年SMN累积发生率分别为6.4%和5.9%,中位随访分别为14.3年和18.1年(HR=1.10;95% BCI 0.61-1.40;P>.05)。
  • 放疗相关SMN超额风险中占比最大的是肺癌(非裔美国人:HR=2.08,95% BCI 1.02-5.39,P<.05;白人:HR=1.50,95% BCI 0.84-5.38,P>.05)。
  • Subpopulation Treatment Effect Pattern Plot(STEPP)分析显示20-44岁人群放疗后非乳腺SMN风险更高,非裔美国人放疗HR更大。
  • 年轻非裔美国女性正常气道上皮放射耐受性评分显著低于年轻白人女性(P=.038)。

临床怎么用

  • 对年轻I-IIIA期乳腺癌女性,尤其是非裔美国人,放疗决策时应充分告知非乳腺SMN(特别是肺癌)的长期风险。
  • 非裔美国女性乳腺癌幸存者放疗后需加强肺癌等第二原发肿瘤的长期监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To estimate the effect of radiation therapy (RT) on nonbreast second malignant neoplasms (SMNs) in young women survivors of stage I-IIIA breast cancer. METHODS AND MATERIALS: Women aged 20 to 44 years who received a diagnosis of stage I-IIIA breast cancer (1988-2008) were identified in the Surveillance, Epidemiology, and End Results 9 registries. Bootstrapping approach and competing-risk proportional hazards models were used to evaluate the effect of RT on nonbreast SMN risk. The analysis was repeated in racial subgroups. Radiotolerance score analysis of normal airway epithelium was performed using Gene Expression Omnibus (GEO) data sets. RESULTS: Within records of 30,003 women with primary breast cancer, 20,516 eligible patients were identified, including 2,183 African Americans (AAs) and 16,009 Caucasians. The 25-year cumulative incidences of SMN were 5.2% and 3.6% (RT vs no-RT) for AAs, with 12.8-year and 17.4-year (RT vs no-RT) median follow-up (hazard ratio [HR] = 1.81; 95% bootstrapping confidence interval [BCI], 1.02-2.50; P < .05), respectively, and 6.4% and 5.9% (RT vs no-RT) for Caucasians with 14.3-year and 18.1-year (RT vs no-RT) median follow-up (HR = 1.10; 95% BCI, 0.61-1.40; P > .05), respectively. The largest portion of excess RT-related SMN risk was lung cancer (AA: HR = 2.08, 95% BCI, 1.02-5.39, P < .05; Caucasian: HR = 1.50, 95% BCI, 0.84-5.38, P > .05). Subpopulation Treatment Effect Pattern Plot (STEPP) analysis revealed higher post-RT nonbreast SMN risk in those 20 to 44 years of age, with larger HRs for RT in AAs. Radiotolerance score (RTS) of normal airway epithelium from young AA women was significantly lower than that from young Caucasian women (P = .038). CONCLUSIONS: With a projected 25-year follow-up, RT is associated with elevated risk of nonbreast SMNs, particularly second lung cancer, in young women survivors of stage I-IIIA breast cancer. Nonbreast SMNs associated with RT are higher in AA women than Caucasian women.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Xie L, Bao X, Cai T, et al. Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer. Int J Radiat Oncol Biol Phys. 2019. PMID: 31201893. doi:10.1016/j.ijrobp.2019.06.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。